{"id":"894204d2-44c2-4f9e-9261-5d64481f866a","companyId":"bc532371-0bd2-47c6-9edc-7f5f701b2a24","modelName":"Indego","slug":"parker-indego","description":"Parker Hannifin's Indego is a powered lower-limb exoskeleton, FDA-cleared via 510(k) in 2016, intended to enable individuals with spinal cord injury at levels T7 to L5 to perform ambulatory functions with supervision of a specially trained companion.","formFactor":"exoskeleton","industryVertical":null,"environment":null,"maturityStage":"research","lifecycleState":"active","supersededByModelId":null,"specs":{"class":"powered lower-limb exoskeleton","clearance":"FDA 510(k) 2016","indication":"SCI T7-L5"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.southcarolinablues.com/web/public/brands/medicalpolicy/external-policies/powered-exoskeleton-for-ambulation-in-patients-with-lower-limb-disabilities/","sourceName":"Parker Hannifin / Indego"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Form factor","value":"powered lower-limb exoskeleton"},{"label":"Clearance","value":"FDA 510(k) 2016"},{"label":"Indication","value":"SCI T7-L5"}],"createdAt":"2026-06-24T07:16:07.432Z","updatedAt":"2026-08-16T04:14:17.537Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/parker-indego","url":"https://registry.deploy.report/models/parker-indego","name":"Indego","description":"Parker Hannifin's Indego is a powered lower-limb exoskeleton, FDA-cleared via 510(k) in 2016, intended to enable individuals with spinal cord injury at levels T7 to L5 to perform ambulatory functions with supervision of a specially trained companion.","identifier":"894204d2-44c2-4f9e-9261-5d64481f866a","category":"exoskeleton","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"research","lifecycle_state":"active","architectural_position":{"cohort":"exoskeleton","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}